Monographie - Pentamidine isetionate - Stabilis 4.0

Siste oppdatering :
08/05/2024

Antibiotika

Pentamidine isetionate

Injeksjon

Oppløsningsstabilitet

Stabilitet i blandinger

Faktorer som påvirker stabiliteten

Kompatibilitet

Administrasjonsmåte

Referanser

Pdf

Kjemisk struktur

Handelsnavn

Handelsnavn

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

DBL Pentamidine isetionate	Malaysia
Manicare	Argentina
Nebupent	USA
Pentacarinat	Belgia, Colombia, Danmark, Finland, Frankrike, Hellas, Italia, Luxembourg, Nederland, New Zealand, Spania, Storbritannia, Sveits, Sverige, Tyskland, Østerrike
Pentam	USA
Pentamidina	Argentina, Spania
Pentamidine isethionate	Australia, Canada, Malaysia, USA
Pentamina	Portugal

Referanser

Injeksjon

Referanser : Pentamidine isetionate

	Type	Publikasjon
36	Journal	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	Journal	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	Journal	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	Journal	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	Journal	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	Journal	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	Journal	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Labratorium	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	Journal	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	Journal	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	Journal	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	Journal	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Labratorium	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Labratorium	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Labratorium	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Labratorium	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales